Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice
Drugs & Therapy Perspectives · 2024-08 · 40 (8) · 315-329
DOI: 10.1007/s40267-024-01079-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drugs & Therapy Perspectives, online erschienen am 18.07.2024. Verfasst von Chueh Hsuan Hsu und 5 weiteren Autor:innen. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 152 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Hsu, C. H., Hsu, C. L., Langley, A., Wojcik, C., Iraganje, E., & Grygiel-Górniak, B. (2024). Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice. Drugs & Therapy Perspectives, 40(8), 315-329. https://doi.org/10.1007/s40267-024-01079-4
Vancouver
Hsu CH, Hsu CL, Langley A, Wojcik C, Iraganje E, Grygiel-Górniak B. Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice. Drugs & Therapy Perspectives. 2024;40(8):315-329. doi:10.1007/s40267-024-01079-4
BibTeX
@article{Hsu2024,
author = {Hsu, Chueh Hsuan and Hsu, Chueh Lin and Langley, Ashley and Wojcik, Caroline and Iraganje, Elysee and Grygiel-Górniak, Bogna},
title = {Glucocorticoid-induced osteoporosis—from molecular mechanism to clinical practice},
journal = {Drugs & Therapy Perspectives},
year = {2024},
volume = {40},
number = {8},
pages = {315--329},
doi = {10.1007/s40267-024-01079-4}
}
EUVIMED